ciglitazone has been researched along with Helicobacter Infections in 1 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Konturek, PC | 1 |
| Kania, J | 1 |
| Kukharsky, V | 1 |
| Raithel, M | 1 |
| Ocker, M | 1 |
| Rembiasz, K | 1 |
| Hahn, EG | 1 |
| Konturek, SJ | 1 |
1 other study available for ciglitazone and Helicobacter Infections
| Article | Year |
|---|---|
Implication of peroxisome proliferator-activated receptor gamma and proinflammatory cytokines in gastric carcinogenesis: link to Helicobacter pylori-infection.
Topics: Adult; Cell Line, Tumor; Cell Proliferation; Cytokines; Female; Gastric Mucosa; Helicobacter Infecti | 2004 |